Lupia, T.; De Benedetto, I.; Bosio, R.; Shbaklo, N.; De Rosa, F.G.; Corcione, S.
Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments. Life 2023, 13, 959.
https://doi.org/10.3390/life13040959
AMA Style
Lupia T, De Benedetto I, Bosio R, Shbaklo N, De Rosa FG, Corcione S.
Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments. Life. 2023; 13(4):959.
https://doi.org/10.3390/life13040959
Chicago/Turabian Style
Lupia, Tommaso, Ilaria De Benedetto, Roberta Bosio, Nour Shbaklo, Francesco Giuseppe De Rosa, and Silvia Corcione.
2023. "Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments" Life 13, no. 4: 959.
https://doi.org/10.3390/life13040959
APA Style
Lupia, T., De Benedetto, I., Bosio, R., Shbaklo, N., De Rosa, F. G., & Corcione, S.
(2023). Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments. Life, 13(4), 959.
https://doi.org/10.3390/life13040959
